StockData
OptimizeRx Corp logo

OptimizeRx Corp (OPRX) stock

OPRXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/3030% below fair value
$7.31+0.37 (+5.33%)

Close on Nov 18, 2026Market cap $137.69MP/E 30.5Yield –

OptimizeRx revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

OptimizeRx's revenue for the twelve months ending Jun 30, 2026 was $98.65M, down 5.8% year over year. For fiscal 2025 it was $109.43M, up 18.8% from the year before. Over ten years it grew 31.2% a year on average. The highest annual figure on record is $109.43M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$109.43M+18.8%
FY2024Dec 31, 2024$92.13M+28.8%
FY2023Dec 31, 2023$71.52M+14.5%
FY2022Dec 31, 2022$62.45M+1.9%
FY2021Dec 31, 2021$61.29M+41.5%
FY2020Dec 31, 2020$43.31M+76.1%
FY2019Dec 31, 2019$24.60M+16.0%
FY2018Dec 31, 2018$21.21M+74.9%
FY2017Dec 31, 2017$12.13M+56.5%
FY2016Dec 31, 2016$7.75M+7.4%
FY2015Dec 31, 2015$7.22M+11.0%
FY2014Dec 31, 2014$6.50M+39.0%
FY2013Dec 31, 2013$4.68M+135.3%
FY2012Dec 31, 2012$1.99M+79.0%
FY2011Dec 31, 2011$1.11M+1464.1%
FY2010Dec 31, 2010$71.07K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$20.50M-29.8%
Q1 FY2026Mar 31, 2026$19.84M-9.5%
Q4 FY2025Dec 31, 2025$32.24M-0.2%
Q3 FY2025Sep 30, 2025$26.07M+22.3%
Q2 FY2025Jun 30, 2025$29.20M+55.2%
Q1 FY2025Mar 31, 2025$21.93M+11.4%
Q4 FY2024Dec 31, 2024$32.32M+13.9%
Q3 FY2024Sep 30, 2024$21.31M+30.5%
Q2 FY2024Jun 30, 2024$18.81M+36.1%
Q1 FY2024Mar 31, 2024$19.69M+51.4%
Q4 FY2023Dec 31, 2023$28.37M+44.3%
Q3 FY2023Sep 30, 2023$16.33M+18.9%
Q2 FY2023Jun 30, 2023$13.82M-32.0%
Q1 FY2023Mar 31, 2023$13.00M-19.4%
Q4 FY2022Dec 31, 2022$19.65M+44.2%
Q1 FY2022Mar 31, 2022$13.73M+22.3%
Q4 FY2021Dec 31, 2021$20.31M+23.7%
Q3 FY2021Sep 30, 2021$16.12M+53.3%
Q2 FY2021Jun 30, 2021$13.63M+55.1%
Q1 FY2021Mar 31, 2021$11.23M+48.1%
Q4 FY2020Dec 31, 2020$16.43M+134.5%
Q3 FY2020Sep 30, 2020$10.52M+101.9%
Q2 FY2020Jun 30, 2020$8.78M+33.5%
Q1 FY2020Mar 31, 2020$7.58M+40.1%
Q2 FY2019Jun 30, 2019$7.01M+37.4%
Q1 FY2019Mar 31, 2019$5.21M+26.7%
Q4 FY2018Dec 31, 2018$6.58M+64.2%
Q3 FY2018Sep 30, 2018$5.42M+74.5%
Q2 FY2018Jun 30, 2018$5.10M+77.9%
Q1 FY2018Mar 31, 2018$4.11M+91.1%
Q4 FY2017Dec 31, 2017$4.01M+74.8%
Q3 FY2017Sep 30, 2017$3.10M+73.7%
Q2 FY2017Jun 30, 2017$2.87M+49.8%
Q1 FY2017Mar 31, 2017$2.15M+22.3%
Q4 FY2016Dec 31, 2016$2.29M–
Q3 FY2016Sep 30, 2016$1.79M–
Q2 FY2016Jun 30, 2016$1.91M–
Q1 FY2016Mar 31, 2016$1.76M–

More OptimizeRx figures

See a number that looks wrong?